Company equips cardiovascular community to navigate shifting health care landscape and enhance operational efficiency

Chicago - At the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 24-27 in Chicago, Siemens Healthcare (booth #2026) will offer solutions for sustainable cardiovascular care to help ensure that cardiovascular professionals are "in it for the long run" - the theme of this year's Siemens booth. Providing a comprehensive portfolio of systems and support solutions that range from imaging modalities to information technology (IT) and in vitro diagnostics, Siemens is uniquely positioned to aid the cardiovascular community in making sound clinical decisions, providing safer procedures, improving operational efficiency, and maximizing its investments in healthcare technology and IT - ultimately helping to make the delivery of cardiovascular care more sustainable.

"At this year's ACC, Siemens is again demonstrating its status as a reliable and innovative partner for our cardiovascular customers, enabling them to not only address changes in the modern cardiovascular landscape, but to thrive as they surmount the challenges that come with those changes," says Claus Grill, vice president, angiographic, cardiac and X-ray systems, Siemens Healthcare. "Our comprehensive portfolio of solutions uniquely positions Siemens to enable providers to consistently deliver high-quality, cost-effective cardiovascular care." This offering of innovative health care solutions at a competitive price is one of the main goals of the Healthcare Sector's recently announced Agenda 2013 global initiative.
Siemens' ability to provide integrated cardiovascular care across multiple imaging modalities is illustrated by the procedure known as transcatheter aortic valve replacement (TAVR). Certain patient subsets - particularly elderly patients with severe aortic stenosis - can benefit from TAVR, which is typically conducted in a hybrid suite. Siemens' workflow solution for TAVR support begins with diagnosis and preprocedural planning, which involves computed tomography (CT); and continues through the minimally invasive treatment and valve replacement portions of the TAVR procedure via intra-procedural 3D imaging to assist the physician in guiding accurate valve placement. Exciting new tools such as 3D intracardiac echocardiography (ICE) have the potential to provide new valve assessment possibilities. Additionally, a cardiovascular imaging and information system can support this workflow by providing a multi-modality workplace for diagnostic image review, dynamic image processing, and evidence-based reporting.

More HCB News